The Claim
Genetic deletion of the creatine transporter in dendritic cells impairs their survival, activation, and ability to stimulate T cell proliferation and cytokine production in mouse models, demonstrating that creatine uptake is necessary for optimal dendritic cell function in the tumor microenvironment.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In mouse models, removing the creatine transporter from dendritic cells reduces their survival, activation, and capacity to trigger T cell proliferation and cytokine release, indicating that creatine uptake is required for normal dendritic cell function in the tumor microenvironment.
See the scientific wording
Genetic deletion of the creatine transporter in dendritic cells impairs their survival, activation, and ability to stimulate T cell proliferation and cytokine production in mouse models, demonstrating that creatine uptake is necessary for optimal dendritic cell function in the tumor microenvironment.
Dendritic cells in tumors take in creatine to make a molecule that keeps their energy supply stable. This energy powers their ability to wake up T cells, signal them to multiply, and tell them to attack cancer. Without creatine, dendritic cells run out of energy, stay inactive, and fail to trigger an immune response.
What the research says
1 studyStudy: Unknown Title
When scientists gave mice extra creatine, their immune cells worked better against tumors — which suggests that these immune cells need creatine to function properly. So if they can't take in creatine, they probably can't work well either.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.